Simplex Trading’s Tango Therapeutics TNGX Stock Holding History

Simplex Trading’s Portfolio TNGX Stock Details TNGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$28.2K	Sell	902 -154	-15%	-$3.81K	﹤0.01%	6813
2026 Q1	$22.1K	Buy	+1,056	New	+$14.7K	﹤0.01%	6697
2025 Q3	–	Sell	-49,901	Closed	-$338K	–	10087
2025 Q2	$255K	Buy	+49,901	New	+$123K	﹤0.01%	4245
2024 Q4	–	Sell	-287	Closed	-$1.33K	–	9638
2024 Q3	$2K	Buy	+287	New	+$2.74K	﹤0.01%	8083
2024 Q1	–	Sell	-170	Closed	-$1K	–	9900
2023 Q4	$1K	Buy	+170	New	+$1.48K	﹤0.01%	8591

Other funds holding TNGX

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Simplex Trading's TNGX Position: Q2 2026 in Review

Simplex Trading reduced its Tango Therapeutics (TNGX) stake by 15% in Q2 2026, selling an estimated $3.81K and leaving 902 shares worth $28.2K. The position accounts for ﹤0.01% of the portfolio, ranked #6813.

Simplex Trading first reported a position in TNGX in Q4 2023 and has held it in 5 quarters since. The position peaked at $255K in Q2 2025. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

Simplex Trading held 902 shares of Tango Therapeutics worth $28.2K as of Q2 2026.
Simplex Trading sold 154 Tango Therapeutics shares in Q2 2026, an estimated $3.81K.
Tango Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #6813 holding.
Simplex Trading first reported a position in Tango Therapeutics in Q4 2023 and has held it in 5 quarters since.
Simplex Trading's Tango Therapeutics position peaked at $255K in Q2 2025.
248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.